Inside the Current Issue
|
|||
|
Cover Story Basic instincts drive Mountain States’ forward momentum |
|||
| Newswire | |||
![]() |
|||
| Purchasing Connection | |||
| Resources | |||
| Show Calendar | |||
| H HPN Hall of Fame H | |||
|
|
|||
| Classifieds | |||
| Issue Archives | |||
| Advertise | |||
| About Us | Home | ||
| Subscribe | |||
| Special Event Photos | |||
|
KSR Publishing, Inc. Copyright © 2009 |
|||
|
hpnonline Daily Update |
|||||||||
|
|
Octobe
October 17, 2008 Download print version
Flu shots a tough sell to healthcare workers Docs find 'Stayin Alive' lives up to its name, with a great beat for reviving stopped hearts TSO3 announces agreement with MAGNET B. Braun presents education guide for best practice in anesthesia CDC collaborates on Preventing Skin Infections program with wrestling coaches Munson Healthcare signs Multi-Suite Lawson Software contract Ties between doctors and stent makers queried Heart doctors and makers of medical devices meeting for their annual convention here got a sobering piece of news on Thursday — two senators are asking tough questions about financial ties between the doctors and the companies. Charles E. Grassley, Republican of Iowa, and Herb Kohl, Democrat of Wisconsin, sent a letter asking the nonprofit group that sponsors the conference, the Cardiovascular Research Foundation, for information about its financial relationships with device manufacturers and drug producers. The senators also sent a letter to Columbia University, which has an affiliation with the Cardiovascular Research Foundation. In a statement, the foundation said it would “comply fully” with the information request. “C.R.F. is committed to maintaining the highest standards of integrity in all of its research and educational activities and ensuring independence, objectivity and scientific rigor in all of its programs,” the statement said. According to the foundation’s most recent tax filing on the website guidestar.org, it had revenue in 2005 of $47.2 million. Columbia University Medical Center issued a statement saying it would respond to the request for information. “It is important to note that Columbia University and its Medical Center have conflict of interest policies and procedures in place, and we expect that they are followed by all members of the faculty," the statement said. The manufacturers cited in the senators’ letters are Abbott Laboratories, Medtronic, Boston Scientific, Johnson & Johnson and Medinol. The annual conference here, known as Transcatheter Cardiovascular Therapeutics (TCT), has attracted hundreds of doctors from around the world who specialize in using devices that are placed in the body through catheters, most notably heart stents. At the meeting, manufacturers of stents and related surgical products or drugs display their products in an exhibition hall. The letters sent Thursday are part of a recent wave of inquiries by Senators Grassley and Kohl into potential conflicts of interests between medical researchers and drug and device companies. The lawmakers are also among those sponsoring legislation that would require the industry to more fully disclose such financial ties. At the same conference on Thursday, researchers released results of a new study indicating that a drug-coated stent called Endeavor, made by Medtronic, was linked to more heart attacks and deadly blood clots than the Cypher stent made by Johnson & Johnson. Shares of the medical device maker Medtronic fell Thursday. Results from the study, which included more than 2,000 patients, showed that heart patients who received the Medtronic device, called Endeavor, had more heart attacks and blood clots and needed repeat procedures more often than those treated with the Johnson & Johnson Cypher stent. (The New York Times) Read the complete story
Visit here for the
complete Medtronic story
NJ flu-shot mandate for preschoolers draws outcry AP - Many New Jersey parents are furious over a first-in-the-nation requirement that children get a flu shot in order to attend preschools and day-care centers. The decision should be the parents', not the state's, they contend. Hundreds of parents and other activists rallied outside the New Jersey Statehouse on Thursday, decrying the policy and voicing support for a bill that would allow parents to opt out of mandatory vaccinations for their children. New Jersey's policy was approved last December by the state's Public Health Council and is taking effect this fall. Children from 6 months to 5 years old who attend a child-care center or preschool have until Dec. 31 to receive the flu vaccine, along with a pneumococcal vaccine. The Health Council was acting on the recommendations of the Centers for Disease Control and Prevention (CDC), which has depicted children under 5 as a group particularly in need of flu shots. But no other state has made the shots mandatory for children of any age. Opposition to the policy is vehement. Assemblywoman Charlotte Vandervalk, one of the speakers at the rally, said she now has 34 co-sponsors for a bill that would allow for conscientious objections to mandatory vaccinations. “The right to informed consent is so basic," she said in an interview. "Parents have a right to decide for their own children what is injected in their bodies." State policy now allows for medical and religious exemptions to mandatory vaccinations, but Vandervalk said requests for medical exemptions often have been turned down by local health authorities. She said 19 other states allow conscientious exemptions like those envisioned in her bill.
State health officials and the CDC insist the flu vaccine is safe and
effective, but Vandervalk and the parent groups who support her bill contend
there has been inadequate research into the vaccine's impact on small
children. Critics note that flu vaccines contain trace amounts of thimerosol,
a mercury-based preservative; the CDC says there's no convincing evidence
these trace amounts cause harm. (Washington Post- Associated Press)
Read the complete
story
Flu shots a tough sell to healthcare workers AP - Operating room nurse Pauline Taylor from University Hospitals and Clinics in Iowa City, knows her refusal to get a flu shot is based on faulty logic. But ever since she got sick after getting a shot a few years ago, she's sworn off the vaccine. Such stories frustrate Dr. William Schaffner. As chairman of the Department of Preventive Medicine at Vanderbilt University, he hears that kind of talk frequently and knows it's in part to blame for a surprising statistic - nearly 60 percent of health- care workers fail to get a flu shot. That's despite recommendations from the CDC that all healthcare workers get vaccinated, from hospital volunteers to doctors. "It is a professional obligation on the part of health care workers to make sure that they are as protected against influenza as possible," Schaffner said. Schaffner argues that getting vaccinated for the flu should be standard for doctors and nurses, just like washing their hands. That's because the flu virus can be spread so easily. "Being in close proximity to patients, having conversations with them, bending over their bed, seeing them in the clinic while you're doing procedures, you would be breathing out viruses and spreading influenza into your patients," said Schaffner, who is also president-elect of the National Foundation for Infectious Diseases. The nonprofit group educates the public and healthcare industry about the causes, treatment and prevention of infectious diseases. It gets about 75 percent of its budget from major vaccine makers, but executive director Len Novick said the money comes with no strings attached. According to the foundation, likely cases of flu outbreaks between healthcare workers and patients include: 19 babies in a neonatal intensive care unit in Ontario, Canada, infected in 2000; one died. Healthcare workers, only 15 percent of whom were immunized, were the likely source. 65 residents of a nursing home in New York got the flu during the 1991-1992 flu season, and two died. Only 10 percent of healthcare workers had been vaccinated before the outbreak, according to a report by the CDC. The CDC recommends that health care facilities offer free flu vaccines to employees annually at work, and that hospitals obtain signed statements from workers who refuse. Several states have laws requiring hospitals to make the vaccines available. At Allen Hospital in Waterloo, Iowa, the flu shot is mandatory for those with direct patient contact and recommended for everyone else. Those with allergies to the vaccine or other conditions can take a pass, but they must supply a note from their doctor. The hospital says the vaccination rate is 93 percent. Some
hospitals take a tougher stand on vaccinations. In
Seattle, at
Virginia
Mason
Medical
Center,
even sales reps, vendors and volunteers must be vaccinated unless they seek
exceptions for religious or medical reasons. Even then, those who don't get
a shot must wear a mask whenever they are in the hospital during the flu
season. About 99 percent of the hospital's more than 5,000 employees were
vaccinated. (Miami
Herald – Associated Press)
Read the complete
article
Docs find 'Stayin Alive' lives up to its name, with a great beat for reviving stopped hearts "Stayin' Alive" might be more true to its name than the Bee Gees ever could have guessed: At 103 beats per minute, the old disco song has almost the perfect rhythm to help jump-start a stopped heart. And in a small but intriguing study from the University of Illinois medical school, doctors and students maintained close to the ideal number of chest compressions doing CPR while listening to the catchy, sung-in-falsetto tune from the 1977 movie "Saturday Night Fever." The American Heart Association recommends 100 chest compressions per minute, far more than most people realize, study author Dr. David Matlock of the school's Peoria, IL, campus said Thursday. And while CPR can triple cardiac arrest survival rates when properly performed, many people hesitate to do it because they're not sure about keeping the proper rhythm, Matlock said. He found that "Stayin' Alive," which has a way of getting stuck in your head anyway, can help with that. His study involved 15 students and doctors and had two parts. First they did CPR on mannequins while listening to the song on iPods. They were asked to time chest compressions with the song's beat. "It drove them and motivated them to keep up the rate, which is the most important thing," he said. The study showed the song helped people who already know how to do CPR, and the results were promising enough to warrant larger, more definitive studies with real patients or untrained people, Matlock said. It turns out the American Heart Association has been using the song as a training tip for CPR instructors for about two years. They learned of it from a physician "who sort of hit upon this as a training tool," said association spokesman Dr. Vinay Nadkarni of the University of Pennsylvania. He said he was not aware of any previous studies that tested the song. Nadkarni said he has seen "Stayin' Alive" work wonders in classes where students were having trouble keeping the right beat while practicing on mannequins. When he turned on the song, "all of a sudden, within just a few seconds, they get it right on the dot." ( ABC News - Associated Press) Read the complete story
American Heart Association:
http://www.americanheart.org/handsonlycpr
TSO3 announces agreement with MAGNET Mr.
W. Barry McDonald, Interim President and CEO of TSO3 Inc., is proud to
announce that TSO3 has been selected as a vendor partner by the Mid-Atlantic
Group Network of Shared Services (MAGNET), one of the oldest and largest
group purchasing organizations in the United States. East coast-based
MAGNET, serves 11,000 healthcare providers by offering access to a contract
portfolio of high-quality capital equipment and services. As a vendor
partner, TSO3 will supply MAGNET’s members with its low temperature ozone
sterilization system for hospital environments. Significant sales are
anticipated in the near-term as a result of this agreement. For more
information, visit
www.tso3.com.
B. Braun presents education guide for best practice in anesthesia B. Braun Medical Inc. (B. Braun) has announced the publication of a first-of-its-kind educational guide, Dual Guidance – A Multimodal Approach to Nerve Location. The educational guide will be introduced at the 2008 Annual Meeting of the American Society of Anesthesiologists (ASA), to be held Oct. 19-21 in Orlando. Authored by three key opinion leaders in the anesthesiology field – Drs. Ralf Gebhard, William Urmey, and Admir Hadzic, with an introduction from Dr. Richard Brull – the four-chapter information resource defines the concept of “dual guidance,” or the use of ultrasound with nerve stimulation, as a best practice for nerve location in modern regional anesthesia, and presents an objective analysis of ultrasound and nerve stimulation studies. Peripheral nerve blocks, which block pain at its source through precise injection of a local anesthetic, are used in an estimated two million procedures each year in North America. Nerve stimulation has long been the “gold standard” for nerve location when performing peripheral nerve blocks, stimulating the nerve and causing the target muscle to twitch. More recently, high-frequency ultrasound imaging has increasingly gained ground as a supplementary or complementary modality as it enables the anesthesiologist to see the nerve and the needle, as well as the spread of local anesthesia. Nerve stimulation and ultrasound-guided regional anesthesia each offer distinct advantages and limitations. Until now, however, a comprehensive information source for anesthesiologists that provides an objective, clinical review of best practices using both technologies did not exist.
Focused on the evolution of nerve location, the educational guide cites
several key nerve stimulation and ultrasound studies that have influenced
the use of nerve stimulation and ultrasound in clinical practice. For more
information or to obtain a complimentary copy of the educational guide,
please email
dualguidance.us@bbraun.com.
CDC collaborates on Preventing Skin Infections program with wrestling coaches The National Wrestling Coaches Association (NWCA) recently announced the release of Preventing Skin Infections, a Web-based seminar that is available for viewing by state high school activity associations, collegiate governing bodies, athletes, parents, certified athletic trainers and other medical personnel. CDC and NWCA collaborated in development of the MRSA topic. The producers also worked with the National Athletic Trainers Association (NATA) and other sports medicine agencies to produce all-sports and sport-specific modules for interactive classroom or one-on-one learning. Keying in on three classifications of microbes—fungi (ringworm), bacteria (Strep and Staph, including MRSA) and virus (Herpes Gladiatorum). The goal is to help protect student-athletes from these pathogens. The seminar movies make extensive use of animation, special effects, graphics, studio and on-location shooting. The seminar is suitable for all sports with a special module devoted to the issues and procedures germane to wrestling. The presentation is informative, entertaining and educational for anyone in any type of skin contact activities. Visit here for the presentation
Munson Healthcare signs Multi-Suite Lawson Software contract Lawson Software announced that Munson Healthcare licensed the Lawson Human Resource Management Suite and Lawson Business Intelligence, part of the Lawson S3 Enterprise Performance Management Suite. The healthcare provider will use the Lawson system to consolidate administrative processes and support its integrated human resources and payroll services. The contract was signed during Lawson’s first quarter of fiscal 2009, which ended Aug. 31, 2008. Munson Healthcare has a medical staff approaching 500 and is affiliated with eight hospitals in northern Michigan, including Munson Medical Center in Traverse City and Paul Oliver Memorial Hospital in Frankfort. The regional health system also consists of an air and ground medical transport service and a home health agency.
Munson Healthcare chose Lawson to support an organization-wide initiative to
simplify and modernize its HR processes. The healthcare provider also wanted
an HR system that would support its evolving technology and business needs.
October 16, 2008 Download print version MedAssets launches Medicare RAC solution for hospitals and health systems Chinese citizens up for debate over healthcare reform Premier CEO Rick Norling to retire US rate of infant death worsens to 29th in world FDA creates web page with drug safety information for patients, healthcare professionals Hospira acquires Endotool from MD Scientific Health firms to study clots in stent patients MedAssets launches Medicare RAC solution for hospitals and health systems MedAssets, Inc. has announced the release of its Medicare Recovery Audit Contractor (RAC) solution to support healthcare providers’ strategies to address RAC audits. MedAssets’ comprehensive RAC solution assists providers throughout the entire RAC audit process – from assessment to appeal – and provides overall revenue integrity solutions for long-term financial performance improvement. It provides a RAC workflow tool that helps hospitals manage RAC audit timelines and activities, automate deadline notifications, track activity and audit historical claims to identify vulnerabilities. In addition, MedAssets consulting services assess reimbursement risk and its RAC appeal and recovery services help providers manage, defend and appeal RAC audits.
Beyond reimbursement management, MedAssets’ suite of revenue cycle
management solutions include concurrent denial management, claims
management, contract management, and web-based data-driven applications that
specifically address revenue integrity in the areas of patient estimates,
charge capture, and clinical documentation. MedAssets’ end-to-end solutions
offer providers a means to close the financial gaps created by RAC audits
and other Centers for Medicare and Medicaid Services (CMS) initiatives.
Visit
www.medassets.com for more information.
Chinese citizens up for debate over healthcare reform BEIJING -- China's new healthcare reform plan, which aims to provide universal medical service to 1.3 billion people, has triggered nationwide debate since it was publicized on Tuesday morning. News articles on healthcare reform showed up in major newspapers and online forums were swarmed with netizens eager to express their opinion. Growing public criticism of soaring medical fees, a lack of access to affordable medical services, poor doctor-patient relationships and low medical insurance coverage compelled the government to launch the new round of reforms. China first started reforming healthcare in 1992 to abolish a system under which the government covered more than 90 percent of expenses. The country then gradually switched to a market-oriented medical system. However, soaring medical costs plunged many rural and urban Chinese into poverty. In the new plan, the government promised to set up a "safe, effective, convenient and affordable" healthcare system that would cover all urban and rural residents by 2020. The draft lists five priorities: speeding up the establishment of a universal healthcare system, setting up a basic drug system, improving the grassroots health service network, providing equal public health service to rural and urban residents and pushing forward reform trials in state-run hospitals. Healthcare reform debates have been going on in China for years. In 2006, the State Council, the country's Cabinet, set up a joint-working team consisting of experts from 16 departments to create a reform plan. It also entrusted nine domestic and overseas organizations, including the World Health Organization, to conduct independent research.
"Healthcare reform is a tough problem worldwide," Peking University
professor Li Ling said. "To mobilize the whole nation to join the debate is
an unprecedented move of the Chinese government, which ensures that the
decision could be made in a prudent, scientific and democratic way." (China
View)
Read the original story.
Premier CEO Rick Norling to retire Richard A. (Rick) Norling will retire as president and chief executive officer of Premier Inc., the nationwide healthcare alliance, on June 30, 2009, the end of his current contract term. A process is underway to have a successor identified well before then and ensure a smooth transition, said Premier Board Chair Lowell C. Kruse, president and CEO of Heartland Health in St. Joseph, Mo. Norling has been planning for his eventual retirement for some time and the succession planning process allows for orderly transition before he leaves. Norling first joined Premier as chief operating officer in 1997, the year after Premier was created through the mergers of three smaller organizations. He became its president and CEO in 1998. Earlier, he was president and chief executive officer of Fairview Hospital and Healthcare System, headquartered in Minneapolis/St. Paul in Minnesota. The
Premier Board and its committees are engaged in the customary work
associated with identifying a successor leader, Kruse reported. An executive
search firm, Spencer Stuart, is engaged to assist the board, and, consistent
with best-practice principles, external and internal candidates are to be
considered.
US rate of infant death worsens to 29th in world Infant deaths in the United States continue to surpass most other rich nations, stalling at the same level from 2000 through 2005 while other countries improved, government researchers said. Latest international data show the US ranking in infant mortality worsened to 29th worldwide, down from 27th in 2000 and 23rd in 1990, according to a report from the National Center for Health Statistics in Hyattsville, Md. Researchers attribute the lack of progress in part to greater numbers of premature births, though the report said preliminary results suggested a small drop in US infant deaths from 2005 to 2006. Infant mortality is one of the most important statistics for researchers assessing the health of nations. Japan, Sweden, Britain, Spain, France, Germany, Australia, and 15 other countries all had infant mortality rates of fewer than 5 deaths for every 1,000 births in 2004, about 26 percent below the US rate of just under seven deaths per 1,000 live births through the last five years for which data are complete, ending in 2005. An
analysis of about 95 percent of US birth records suggests a 2 percent
decline in infant mortality in 2006, MacDorman said. The US ranking of 29th
puts it even with Poland and Slovakia. Blacks had the highest rate of infant
mortality in 2005, at 13.63 deaths per 1,000 live births, or about double
the national average. Rates among Puerto Ricans and Native Americans topped
eight deaths per 1,000 live births.
Read the original story.
FDA creates web page with drug safety information for patients, healthcare professionals Consumers and healthcare professionals can now go to a single page on the U.S. Food and Drug Administration's Web site to find a wide variety of safety information about prescription drugs. The Web page, http://www.fda.gov/cder/drugSafety.htm, provides links to information on: drug-specific safety information and safety sheets; drug labeling and patient package inserts; drugs that have a Risk Evaluation and Mitigation Strategy (REMS) to ensure that their benefits outweigh their risks; a searchable database of postmarket studies with additional information about a drug's safety, efficacy, or optimal use; a searchable database of clinical trials, including information about each trial's purpose, who may participate, locations, and useful phone numbers. Also included: Warning Letters, Import Alerts, Recalls, Market Withdrawals, and Safety Alerts; Regulations and guidance documents; Instructions how to report problems to the FDA through its MedWatch program.
Establishing such a web page is one of the requirements of the Food and Drug
Administration Amendments Act of 2007, and is among FDA's many efforts to
address the safe use of drugs throughout their lifecycle.
Hospira acquires Endotool from MD Scientific Hospira, Inc. announced yesterday that it has acquired the EndoTool business from MD Scientific, LLC. The EndoTool glucose management system is a FDA approved software system which helps establish and maintain glycemic control in acute, critical care and operating room settings by calculating the dose of intravenous (I.V.) insulin needed to effectively control blood glucose levels. Traditionally, nurses and other clinicians use paper-based protocols to manually monitor and adjust I.V. insulin dosing. The EndoTool software system is easy to operate, runs on a hospital's existing computer system and can interface with a hospital information system (HIS). EndoTool actively models and adapts to individual patient responses to I.V. insulin to help manage current and predict future dosage levels. It is the only software that uses five separate data points -- based on the patient's most recent blood glucose readings -- to provide personalized, safe and effective glycemic control. As
part of the agreement, Hospira acquired additional assets related to the
EndoTool business, including the MD Scientific headquarters in Charlotte, N.
C., and the employees supporting the product. Financial details of the
agreement were not disclosed.
www.hospira.com
Health firms to study clots in stent patients In an unusual display of collaboration, eight medical companies are joining forces to launch a $100 million study to determine how best to protect heart patients from rare but dangerous clots after they are treated with artery-opening devices called stents. The four-year, 20,000-patient study is intended to determine whether stent patients can safely go off aggressive blood-thinning treatment after one year, or if they'd be better to remain on the medication for at least 2˝ years after getting a stent. Current guidelines call for patients who get a drug-coated stent to remain on the medicine for at least a year. But concern that, in rare instances, clots can form in the devices well over a year after they are implanted, with potentially lethal consequences, has left doctors and patients in a quandary over how long treatment should be prescribed. Four of the companies are stent makers Boston Scientific Corp., Johnson & Johnson, Medtronic Inc. and Abbott Laboratories Inc. The companies are fierce rivals in the $5 billion global market for the devices. Four drug companies are also participating. Bristol-Myers Squibb Co. and Sanofi Aventis SA co-market the antiplatelet drug Plavix, which combined with aspirin makes up the current regimen for most stent patients. They are bracing for competition from Eli Lilly & Co. and Daiichi Sankyo of Japan, which are co-developing prasugrel, which is awaiting FDA approval. The
study is the result of an FDA request for stent and drug makers to determine
the optimal duration for blood thinning. Separately at the heart meeting, a
Boston Scientific-sponsored study suggested that heart-attack victims fare
better with drug-coated stents instead of older bare-metal models.
Wednesday's study found coated stents reduced the need for repeat procedures
within a year to 4.5% from 7.5%. It didn't find a difference between the two
stents' safety.
Read the original story,
Goodroe Healthcare Solutions earns first approval from the Inspector General for a multi-year gainsharing project Goodroe Healthcare Solutions, LLC, a VHA company, announced that the U.S. Department of Health and Human Services' Office of the Inspector General (OIG) has approved a three-year gainsharing project for cardiovascular procedures. This is Goodroe's first approval for a multi-year project and its twelfth OIG approval. Gainsharing allows hospitals to share cost savings with participating physicians who achieve operational efficiencies. Currently, Goodroe's gainsharing model is used in clinical areas where physicians control the majority of costs, such as cardiac catheterization procedures, open heart surgery and orthopedic and spine procedures. While arrangements with individual hospitals vary, most allow participating physicians to be paid as much as 50 percent of the savings generated through increased hospital and physician collaboration to decrease overall costs while demonstrating quality patient outcomes. Goodroe has used its approved gainsharing methodology to identify nearly $75 million in savings for hospitals while ensuring the best quality of care for patients.
Goodroe's gainsharing model is based on documented patient information
collected by Goodroe's proprietary software and database while the patient
is receiving care. Visit
www.goodroe.com for more information.
October 15, 2008 Download print version 3M RAC ready program helps hospitals identify compliance risks, prepare for RAC audits LSU Health Care Services selects IntelliDOT as its barcode point-of-care partner Johnson & Johnson posts strong results World Health Report calls for return to primary healthcare approach Hospitals protest new California rules on patient billing
Kimberly-Clark Health Care adds two-hour option to oral care kit portfolio
Broadlane to manage procurement and
materials management at Tenet Healthcare Corporation’s 52
hospitals
Broadlane has announced that Tenet Healthcare Corporation
(THC) in Dallas, TX, has outsourced its materials management
and procurement functions for its 52 hospitals. In September,
Tenet signed a seven-year agreement with Broadlane to manage
its approximate $1.5 billion in annual spend. Beginning
January 1, 2009 and continuing through early 2010, Tenet’s
approximately 200 materials management and procurement
employees will become Broadlane employees.
With the addition of Tenet Healthcare, Broadlane will provide outsourced
supply chain management services to 110 acute care hospitals, manage more
than $4 billion in annual supply spend and employ 375 outsourced supply
chain management specialists.
Broadlane will provide national GPO portfolio management, regional GPO
portfolio management and custom agreements for Tenet. In addition, Broadlane
will assume day-to-day responsibility for receiving and internal product
distribution, inventory management and Value Analysis Teams (VAT)
management. Tenet will continue to utilize Broadlane Informatics for access
to reports and to improve insight related to contracts, capital equipment,
pharmacy and other key areas of spend management.
In addition to all materials and inventory management functions, Broadlane
will support Tenet with Procurement Services, supporting the purchasing
processes related to supply chain products, consumable goods, purchased
services and capital equipment and manage Tenet’s item master. Broadlane’s
Item Master Services, also part of Procurement Services, will manage
processes and data related to Tenet’s item master. For more visit
www.broadlane.com
GAO
report: Variation in standards and guidance limits comparison of how
nonprofit hospitals meet community benefit requirements
Nonprofit hospitals qualify for federal tax exemption from the Internal
Revenue Service (IRS) if they meet certain requirements. Since 1969, IRS has
not specified that these hospitals have to provide charity care to meet
these requirements, so long as they engage in activities that benefit the
community. Many of these activities are intended to benefit the
approximately 47 million uninsured individuals in the United States who need
financial and other help to obtain medical care.
Previous studies indicated that nonprofit hospitals may not be defining
community benefit in a consistent and transparent manner that would enable
policymakers to hold them accountable for providing benefits commensurate
with their tax-exempt status. IRS’s community benefit standard allows
nonprofit hospitals broad latitude to determine the services and activities
that constitute community benefit. Furthermore, state community benefit
requirements that hospitals must meet in order to qualify for state
tax-exempt or nonprofit status vary substantially in scope and detail.
GAO found that among the standards and guidance used by nonprofit hospitals,
consensus exists to define charity care, the unreimbursed cost of
means-tested government healthcare programs (programs for which eligibility
is based on financial need, such as Medicaid), and many other activities
that benefit the community as community benefit. However, consensus does not
exist to define bad debt (the amount that the patient is expected to, but
does not, pay) and the unreimbursed cost of Medicare (the difference between
a hospital’s costs and its payment from Medicare) as community benefit.
Variations in the activities nonprofit hospitals define as community benefit
lead to substantial differences in the amount of community benefits they
report.
With the added attention to community benefit has come a growing realization
of the extent of variability among stakeholders in what should count and how
to measure it. At present, determination and measurement of activities as
community benefit for federal purposes are still largely a matter of
individual hospital discretion. Given the large number of uninsured
individuals, and the critical role of hospitals in caring for them, it is
important that federal and state policymakers and industry groups continue
their discussion addressing the variability in defining and measuring
community benefit activities. Click
here.
3M
RAC ready program helps hospitals identify compliance risks, prepare for RAC
audits
3M
Health Information Systems has introduced the 3M RAC Ready Program, a new
solution that combines expert consulting with advanced software to help
hospitals prepare for increased compliance scrutiny under the federal
government's
Recovery Audit Contractor (RAC) program.
The program provides comprehensive tools and services to identify areas of
risk, reduce audit vulnerability, and promote fast and efficient responses
to RAC activities.
Mandated
by Congress and administered by the Centers for Medicare and Medicaid
Services (CMS), the RACs seek to identify improper Medicare payments through
in-depth auditing of hospitals, physicians, and suppliers that submit claims
to the Medicare Fee-for-Service program.
The 3M
RAC Ready Program builds on the foundation of the
3M Coding and Reimbursement System,
which promotes accurate, complete and compliant coding. Core components
include 3M Validation and Appeal Services for Recovery Audit Contractors (RACs),
a complete baseline assessment that determines a hospital's exposure under
the RAC program. 3M consultants work onsite with clients to target areas of
risk, focusing on coding, medical necessity and documentation to improve
claims accuracy and reduce denials.
The
3M Audit Expert System
works in conjunction with the 3M Coding and Reimbursement System to review
100 percent of inpatient records for compliance errors at the point of
coding, and
offers customized coding alerts, retrospective auditing tools, and trending
reports that allow comparisons with national norms. The software features a
RAC tracking and management tool that streamlines workflow by tracking RAC
communications, denials and related appeals, monies recovered, and areas of
risk. For more information visit
here
LSU
Health Care Services selects IntelliDOT as its barcode point-of-care partner
IntelliDOT Corporation, a provider of wireless handheld, barcode
point-of-care (BPOC) solutions to hospitals, announced that the Louisiana
State University Health Care Services Division (LSUHCSD) has selected
IntelliDOT Bedside Medication Administration, Vital Signs Collection and
Mother-Baby Breast Milk Matching modules as part of an enhanced patient
safety initiative. LSUHCSD is a division of the Louisiana State University
Health System, Baton Rouge, LA and consists of seven hospitals with 704 beds
and 300 outpatient clinics that serve the underprivileged and uninsured in
Louisiana. LSUHCSD is one of the largest public hospital systems in the
United States.
The IntelliDOT Bedside Medication Administration prompts the nurse through
medication administration workflows at the bedside. The system is used to
verify the five rights of medication administration: right medication, right
dose, right route, right patient, and right time. Each nurse receives
customized prompts and warnings to assure medications are administered and
documented correctly.
IntelliDOT Mother-Baby Breast Milk Matching – Using the same handheld device
and a small portable wireless printer, a nurse prints barcode labels for
milk containers at the time milk is received from the mother or the mother
can take and apply the labels at home. At administration, the infant’s ID
band is scanned along with the breast milk container, assuring positive
identification and accurate feeding.
IntelliDOT Vital Signs Collection – Vital signs information plus virtually
any clinical documentation can be captured using the same handheld device.
The captured data can populate the eMAR or electronic flow sheets and/or
print on separate patient-specific flow sheets. For more information visit
here.
Johnson & Johnson
showed resilience Tuesday in the face of an economic downturn, posting
higher third-quarter sales and earnings. Because the large medical products
company is more broadly diversified than many other drug and medical device
makers, Johnson & Johnson’s report is not necessarily considered a
bellwether for the entire healthcare industry. Hospitals, for example, tend
to be retrenching, squeezed by the
credit crisis
and concerns about patients’ ability to pay their bills.
But
healthcare products, like the artificial joints made by Johnson & Johnson’s
DePuy division, may be less subject to the economic winds buffeting most
sectors of the economy.
“Everything we’ve seen so far has shown that healthcare has been pretty
defensive and volumes have not been affected by the downturn in the
economy,” said David H. Roman, a medical devices analyst for
Morgan Stanley.
For
example, up to 70 percent of hip and knee replacements, a large part of the
medical device industry, are performed on
Medicare
beneficiaries — a group whose
insurance coverage is guaranteed and who would be unlikely to delay surgery
because of the economy. And, as Roman said, Medicare beneficiaries are
growing in numbers.
Another medical products company, Abbott, is set to announce its earnings
Wednesday morning. Many analysts predict those numbers will also be strong,
largely because of the company’s Xience drug-coated heart stent, a device
that has become popular among interventional cardiologists, Roman said.
Xience’s success is coming in part at the expense of Johnson & Johnson’s
Cypher stent, which is one of the rare devices in the company’s portfolio
that did not show solid growth.
In
Johnson & Johnson’s earnings call with analysts on Tuesday, Dominic Caruso,
the chief financial officer, said that the company’s access to
commercial paper
had been unfettered and available at what he called “very, very good” rates.
That could bode well for other health products company.
Johnson & Johnson announced sales of $15.9 billion for the third quarter, up
6.4 percent from a year earlier. Excluding special charges, the company said
it earned $1.17 a share in the third quarter, versus 88 cents a year
earlier. (NY Times) Visit
here for the complete story.
World Health Report calls for return to primary healthcare approach
The World Health Report 2008 critically assesses the way that healthcare is
organized, financed, and delivered in rich and poor countries around the
world. The WHO report documents a number of failures and shortcomings that
have left the health status of different populations, both within and
between countries, dangerously out of balance. The report, titled
PrimaryHealth Care – now more than ever, commemorates the 30th anniversary
of the Alma-Ata International Conference held in 1978. That event was the
first to put health equity on the international political agenda.
In a wide-ranging review, the new report found striking inequities in health
outcomes, in access to care, and in what people have to pay for care.
Differences in life expectancy between the richest and poorest countries now
exceed 40 years. Of the estimated 136 million women who will give birth this
year, around 58 million will receive no medical assistance whatsoever during
childbirth and the postpartum period, endangering their lives and that of
their infants.
Globally, annual government expenditure on health varies from as little as
US$ 20 per person to well over US$ 6000. For 5.6 billion people in low- and
middle-income countries, more than half of all healthcare expenditure is
through out-of-pocket payments. With the costs of healthcare rising and
systems for financial protection in disarray, personal expenditures on
health now push more than 100 million people below the poverty line each
year.
Data set out in the report are indicative of a situation in which many
health systems have lost their focus on fair access to care, their ability
to invest resources wisely, and their capacity to meet the needs and
expectations of people, especially in impoverished and marginalized groups.
As the report notes, conditions of “inequitable access, impoverishing costs,
and erosion of trust in healthcare constitute a threat to social stability.”
To steer health systems towards better performance, the report calls for a
return to primary healthcare, a holistic approach to healthcare formally
launched 30 years ago. When countries at the same level of economic
development are compared, those where healthcare is organized around the
tenets of primary healthcare produce a higher level of heath for the same
investment.
In far too many cases, people who are well-off and generally healthier have
the best access to the best care, while the poor are left to fend for
themselves. Healthcare is often delivered according to a model that
concentrates on diseases, high technology, and specialist care, with health
viewed as a product of biomedical interventions and the power of prevention
largely ignored. WHO estimates that better use of existing preventive
measures could reduce the global burden of disease by as much as 70%. Visit
here for the complete summary.
Hospitals protest new California rules on patient billing
California emergency room patients can no longer be stuck with the bill when
hospitals or physicians disagree with insurance companies on their fees.
Under new state rules that take effect today, hospitals and physicians are
barred from billing patients for the balance of emergency care not covered
by insurers. But the relief for patients may not last long. Hospitals and
physicians are protesting the rules in court. Meanwhile, the state Supreme
Court is set to hear another "balance billing" challenge next month.
Department director Cindy Ehnes, called Prime a "serial balance biller whose
actions have unjustly threatened the credit rating of thousands of
Californians." Ehnes said she wanted to take patients out of the middle of
billing disputes between insurers, hospitals and physicians.
The department also announced that it would address what Ehnes called "the
root cause of balance billing", the unfair or late payment of legitimate
emergency room claims by insurers. She said the department would add
resources to speed up the resolution of hospital and physician complaints
over such practices.
Kimberly-Clark Health Care adds two-hour option to oral care kit portfolio
Kimberly-Clark Health Care announced today that as part of its ongoing
commitment to providing clinicians with a range of effective clinical
solutions and best practice education to address Ventilator-Associated
Pneumonia (VAP), it has added the KimVent Oral Care q2 Kit to its portfolio
of oral care solutions. Now, caregivers will have the ability to administer
oral hygiene care every two hours to ventilator-dependent patients at risk
for VAP. A
leader in developing clinical solutions against healthcare-associated
infections, Kimberly-Clark Health Care introduced the KimVent Oral Care q4
Kit in October 2007. With the addition of the new KimVent Oral Care q2 Kit,
along with individual components and packs, Kimberly-Clark Health Care now
allows caregivers the flexibility to choose from a portfolio of oral care
solutions. The KimVent Oral Care portfolio is designed to provide
comprehensive oral care for individual patient needs as well as q2 and q4
hospital oral care protocols, helping to meet clinical recommendations from
organizations such as the Centers for Disease Control and Prevention and the
American Association for Critical Care Nurses for an oral hygiene program
for at-risk patients.
The new KimVent Oral Care q2 Kit includes all components of the original q4
Kit, but also contains extra features for more frequent oral care
administration. Unique to the q2 Kit are six additional suction swab packs
with alcohol-free mouthwash and a color-coded “Order of Use Guide.” The
guide provides nurses with easy identification of component packs and
step-by-step visual instructions to promote proper continuity of care and
compliance as well as support both individual patient needs and hospital
oral care protocol.
Designed by nurses, for nurses to address the challenges associated with
oral care products, the KimVent Oral Care q4 and q2 products incorporate a
convenient and portable design as well as ergonomic and user-friendly tools.
Both kits can be kept at the patient’s bedside and contain individual
procedure packs that allow nurses to choose the appropriate tools easily.
For more information visit
http://www.kchealthcare.com/kimvent.
October
14, 2008
Download print version
Serotype 19A infection eludes a leading
children’s vaccine
Cancer
screening rates among older Medicaid patients fall short of national
objectives
Intensive support programs can help hospitalized smokers stay smoke-free
HealthGrades annual hospital quality study shows death rate 70 percent lower
at top-rated hospitals
Researchers discover baldness gene: 1 in 7 men at risk
How
workable are the presidential candidates' health reform plans?
Vitamin D a key player in overall health of several body organs and
Parkinsons Disease
Doctors double vitamin D for children
Serotype 19A infection eludes a leading
children’s vaccine
A highly drug-resistant germ has become a common cause of
meningitis,
pneumonia
and other life-threatening conditions in young children. The
culprit — a strain of strep bacteria — can conquer almost all
antibiotics
in
pediatrics,
and has dodged a vaccine otherwise credited with causing the
number of serious infections in children to plummet.
Since
2000, American toddlers have been immunized against Streptococcus pneumoniae,
or pneumococcus, an organism that preys largely on children younger than 5
and the elderly.
Pneumococcal meningitis
can be fatal, and survivors are often left with
deafness and
other lifelong neurological problems. By most measures, the vaccine has
worked: by 2002, rates of infection from these bacteria had dropped as much
as 80 percent in some places. But progress has now stalled, and infection
with a particular type of pneumococcus, Serotype 19A, is steadily rising.
“It’s
very much a concern,” said Bernard Beall, a pneumococcal expert at the
federal
Centers for Disease
Control and Prevention. Last year, in The Journal of the
American Medical Association, pediatricians described an outbreak of
Serotype 19A ear infections in Rochester that could be cured only by
surgically implanting tubes, or by turning to adult medicines not yet tested
for safety in
children. A
greater worry, however, is the frequency of meningitis, pneumonia and
bloodstream infections from Serotype 19A. Since 2001, rates of these and
other invasive pneumococcal diseases have crept upward, to more than 10 per
100,000 children from about 2 per 100,000. A fourfold increase in
life-threatening infections has also occurred among the elderly.
The vaccine Prevnar is aimed at seven types of bacteria that were
responsible for 70 to 80 percent of pneumococcal illness during the 1990s.
Because pneumococci come in 91 forms, experts have worried from the start
whether bacteria that were just as deadly, but not wiped out by the vaccine,
might move in as opportunists when the competition suddenly vanished.
The bacteria live in the nose and throat, usually as microbial freeloaders
of no consequence. Occasionally — often after a simple viral infection —
pneumococci slip into inner areas of the body and cause disease. Weaker
immune systems in the very young and the very old leave them most
vulnerable. The pneumonia shot in older people includes 19A. Not all of the
91 incarnations of pneumococcal bacteria are dangerous. The variation in
genes slightly alters how the bacteria function and how they are received by
the immune system.
For vaccine manufacturers, pneumococci’s diversity presented a challenge:
how to teach the immune system to recognize a target that may look a little
different from child to child. Serotype 19A was around in the 1990s, though
uncommon, and the vaccine includes a similar version called 19F. The hope in
2000 was that 19F looked enough like 19A to set off an immune reaction. It
did not.
The vaccine’s manufacturer, Wyeth, says it has been working quickly to
develop a new product to counter 19A and five other pneumococcal variations,
along with the original seven. The company will release results of the first
large studies of the newer version this month at an infectious disease
meeting in Washington. (NY Times) Visit
here for the complete story.
Cancer screening rates among older Medicaid patients fall short of national
objectives
Only about half of Medicaid recipients age 50 and older appear to receive
recommended screening tests for colorectal, breast and cervical cancer,
according to a report in the October 13 issue of Archives of Internal
Medicine. These three types of cancer are potentially curable when
detected early, and eliminating disparities in screenings is part of the
government's Healthy People 2010 plan. "State Medicaid agencies are in a
unique position to monitor and improve the quality of care received by some
of the nation's most vulnerable citizens," the authors write.
"Documentation that colorectal, breast and cervical cancer screening was
recommended by the primary care provider was found for only 52.7 percent,
60.4 percent and 51.5 percent of eligible patients, respectively," the
authors write.
"Documented rates of adequate screening were 28.2 percent for colorectal
cancer, 31.7 percent for mammography within two years and 31.6 percent for
Papanicolaou [cervical cancer] test within three years. When medical record
and claims data were combined, approximately half of eligible patients had
evidence of screening."
Despite Medicaid recipients' access to primary care and full coverage of
cancer screening services, these rates are substantially lower than those in
the general population, the authors note. "Lack of a screening
recommendation by the physician, rather than patient refusal of recommended
tests, accounted for most instances of screening delinquency," they
conclude. "Efforts to increase cancer screening rates among Medicaid
recipients must address patient, physician and organizational barriers to
the routine identification and delivery of preventive services."
Intensive support programs can help hospitalized smokers stay smoke-free
Hospital-sponsored stop-smoking programs for inpatients that include
follow-up counseling for longer than one month significantly improve
patients' ability to stay smoke-free. An analysis of clinical trials of
programs offered at hospitals around the world finds that efforts featuring
long-term support can increase participant's chances of success by 65
percent. The study – led Nancy Rigotti, MD, director of the Tobacco Research
and Treatment Center at Massachusetts General Hospital (MGH) – appears in
the October 13 Archives of Internal Medicine and is one of several
articles focused on smoking.
"While nobody looks forward to a hospital stay, it can really have an extra
benefit for smokers" said Rigotti. "But this is only if the hospital helps
them quit with counseling during and after their hospital stay. Hospitals
really need to step up to the plate and offer this type of service
routinely, and it also should be reimbursed by payors."
Analyzing hospital-based efforts according to their intensity – a single
brief smoking-related contact, one or more extended contacts during
hospitalization, hospital contact plus a month or less of post-discharge
telephone support, and hospital contact followed by more than a month of
post-discharge support – revealed that only programs with the highest
intensity level were more successful than usual care in helping patients
quit for six months or longer.
Although the success rate for patients admitted with cardiovascular disease
was a bit higher, intensive counseling was successful for all hospitalized
smokers, regardless of their diagnosis.
The program offered at MGH begins by automatically flagging patients'
smoking status upon admission and giving each patient who smokes a booklet
addressing how to use their stay to help them quit smoking. Dedicated
smoking-cessation counselors visit with patients during their
hospitalization and call them after discharge to check on their progress and
offer further assistance. Because of this program and other stop-smoking
efforts, the hospital increased its JCAHO/CMS smoking measure score to 100
percent.
HealthGrades annual hospital quality study shows death rate 70 percent lower
at top-rated hospitals
Patients have on average a 70 percent lower chance of dying at the nation's
top-rated hospitals compared with the lowest-rated hospitals across 17
procedures and conditions analyzed in the eleventh annual HealthGrades
Hospital Quality in America Study, issued today. While overall death rates
declined from 2005 to 2007, the nation's best-performing hospitals were able
to reduce their death rates at a much faster rate than poorly performing
hospitals, resulting in large state, regional and hospital-to-hospital
variations in the quality of patient care, the study found.
HealthGrades Hospital Quality in America study also found that if all
hospitals performed at the level of five-star rated hospitals, 237,420
Medicare deaths could potentially have been prevented over the three years
studied. More than half of those deaths were associated with four
conditions: sepsis, pneumonia, heart failure and respiratory failure.
Full reports on death rate trends in each of the 50 states and the District
of Columbia are available in the study. And, for the first time,
HealthGrades has released hospital death rates for the nation's 15 largest
metropolitan statistical areas. Large variation exists between major
metropolitan areas.
Large gaps persist between the "best" and the "worst" hospitals across all
procedures and diagnoses studied. Five star-rated hospitals had
significantly lower risk-adjusted mortality across all three years studied.
Across all procedures and diagnoses studied, there was an approximate 70
percent lower chance of dying in a 5-star rated hospital compared to a
1-star rated hospital. Across all procedures and diagnoses studied, there
was an approximate 50 percent lower chance of dying in a 5-star rated
hospital compared to the U.S. hospital average.
The full study and state-by-state hospital-quality statistics can be found
at
www.healthgrades.com.
Researchers discover baldness gene: 1 in 7 men at risk
Researchers at McGill University, King's College London and GlaxoSmithKline
Inc. have identified two genetic variants in caucasians that together
produce an astounding sevenfold increase the risk of male pattern baldness.
Their results were published Oct. 12 in the journal Nature Genetics.
About a third of all men are affected by male pattern baldness by age 45.
The condition's social and economic impact is considerable: expenditures for
hair transplantation in the United States alone exceeded $115 million (U.S.)
in 2007, while global revenues for medical therapy for male-pattern baldness
recently surpassed $405 million. Male pattern baldness is the most common
form of baldness, where hair is lost in a well-defined pattern beginning
above both temples, and results in a distinctive M-shaped hairline.
Estimates suggest more than 80 percent of cases are hereditary.
The researchers conducted a genome-wide association study of 1,125 caucasian
men who had been assessed for male pattern baldness. Researchers have long
been aware of a genetic variant on the X chromosome that was linked to male
pattern baldness, said Dr. Brent Richards of McGill University's Faculty of
Medicine and the affiliated Jewish General Hospital. "That's where the idea
that baldness is inherited from the mother's side of the family comes from,"
he explained. "However it's been long recognized that that there must be
several genes causing male pattern baldness. Until now, no one could
identify those other genes. If you have both the risk variants we discovered
on chromosome 20 and the unrelated known variant on the X chromosome, your
risk of becoming bald increases sevenfold."
"What's startling is that one in seven men have both of those risk variants.
That's 14 percent of the total population!"
How
workable are the presidential candidates' health reform plans?
John McCain and Barack Obama's health reform plans are different both in
their approaches to solving problems and their potential effects on voters.
But to choose wisely, you have to do some homework. To help, the Los
Angeles Times offers a guide to online resources that analyze how well
the candidates' proposals might work.
Here's a summary of their proposals and a list of online resources for more
information from the Times.
John McCain would… -
Deregulate insurance markets, allowing insurers to sell across state lines.
People could buy less costly, less comprehensive policies in states with
fewer mandates.
The
United States spent $2.1 trillion on healthcare in 2006, according to
national health
expenditure data from the Centers for Medicare and Medicaid
Services. That number is expected to hit $4.3 trillion by the end of 2017 –
19.5% of the gross domestic product.
The
percentage of people with employer-based health insurance fell from 70% in
1987 to 59% in 2006, according to the
National Coalition on
Health Care. Enrollment in high-deductible health plans with
savings options rose from 5% in 2007 to 8% in 2008, according to the
Employer Health Benefits
2008 Annual Survey. More than 42 million U.S. residents, or 14%
of the population, lack insurance, according to the
most recent National
Health Interview Survey.
Vitamin D a key player in overall health of several body organs and
Parkinsons Disease
Essential for life in higher animals, vitamin D, once linked to only bone
diseases such as rickets and osteoporosis, is now recognized as a major
player in contributing to overall human health, emphasizes UC Riverside's
Anthony Norman,
an international expert on vitamin D. In a paper published in the August
issue of the
American Journal of
Clinical Nutrition, Norman identifies vitamin D's potential
for contributions to good health in the adaptive and innate immune systems,
the secretion and regulation of insulin by the pancreas, the heart and blood
pressure regulation, muscle strength and brain activity. In addition, access
to adequate amounts of vitamin D is believed to be beneficial
towards reducing the risk of cancer.
Norman also lists 36 organ tissues in the body whose cells respond
biologically to vitamin D, including bone marrow, breast, colon, intestine,
kidney, lung, prostate, retina, skin, stomach and the uterus. According to
Norman, deficiency of vitamin D can impact all 36 organs.
Vitamin D is synthesized in the body in a series of steps. First, sunlight's
ultraviolet rays act on a precursor compound in skin. When skin is exposed
to sunlight, a sterol present in dermal tissue is converted to vitamin D,
which, in turn, is metabolized in the liver and kidneys to form a hormone.
Norman's laboratory discovered, in 1967, that vitamin D is converted into a
steroid hormone by the body.
The recommended daily intake of vitamin D is 200 international units (IU)
for people up to 50 years old; 400 IU for people 51 to 70 years old and 600
IU for people over 70 years old. Norman's recommendation for all adults is
to have an average daily intake of at least 2,000 IU. About half of the
elderly in North America and two-thirds of the rest of the world are not
getting enough vitamin D to maintain healthy bone density, lower their risks
for fracture and improve tooth attachment.
"There needs to be a sea change by various governmental agencies in terms of
the advice they present to citizens about how much vitamin D should be
taken," Norman said. "The tendencies of people to live in cities where tall
buildings block adequate sunlight from reaching the ground, to spend most of
their time indoors, to use synthetic sunscreens that block ultraviolet rays,
and to live in geographical regions of the world that do not receive
adequate sunlight all contribute to the inability of the skin to
biosynthesize sufficient amounts of vitamin D."
In another study from Emory University School of Medicine, a majority of
Parkinson's disease patients had insufficient levels of vitamin D. The
fraction of Parkinson's patients with vitamin D insufficiency, 55 percent,
was significantly more than patients with Alzheimer's disease (41 percent)
or healthy elderly people (36 percent). The results are published in the
October issue of Archives of Neurology.
Doctors double vitamin D for children
The American Academy of Pediatrics is set to announce it is doubling the
amount of vitamin D it recommends for infants, children, and adolescents to
400 IU a day, beginning in the first few days of life.
"I don't know of another vitamin that has effects on multiple tissues like
vitamin D," said vitamin D researcher Dr. Catherine Gordon, director of the
bone health program at Children's Hospital Boston. "As pediatricians, we're
still doing research on health outcomes, (and) the relation between vitamin
D deficiency during childhood or adolescence and outcomes later in life like
osteoporosis, cancer risk, and risk of developing multiple sclerosis. But
there are compelling data in adults suggesting an association."
That growing awareness, along with the historical precedence of safely
giving 400 IU per day to children, prompted the American Academy of
Pediatrics to change its vitamin D recommendation. Even the new 400
international units dose is "a very conservative recommendation" to prevent
rickets and vitamin D deficiency in all children, said Dr. Carol Wagner, a
pediatrician at the Medical University of South Carolina and a member of the
American Academy of Pediatrics Section on Breast-feeding Executive
Committee.
Earlier this year, researchers at Children's Hospital Boston found
"suboptimal" levels of vitamin D in 40 percent of 380 otherwise healthy
infants and toddlers, with 12 percent considered to be clinically deficient.
Breast-fed infants were up to 10 times more likely to be deficient in
vitamin D than their formula-fed counterparts, according to the study
published in the Archives of Pediatrics and Adolescent Medicine.
Today, vitamin D deficiency is rampant because we're coated in sunscreen –
in order to avoid skin cancer – or not outdoors enough to soak up the right
amount, doctors say. But they aren't recommending sunbathing or tanning beds
because they can't determine a safe amount of sunlight exposure to
synthesize vitamin D in a given individual. In individuals, vitamin D status
differs by distance from the equator and race, with residents of the
Northeast and people with more skin pigmentation being at increased risk of
deficiency. (Boston Globe) Visit
here for the complete story.
October
13, 2008
Download print version
FDA and PATH malaria vaccine initiative
announce research collaboration
Family
blames soldier's suicide on anti-malaria drug
Major
study of opiate use in children's hospitals provides simple steps to
alleviate harm
CRC
screening before Medicare age could save millions in federal healthcare
dollars
Factors other than antibiotics may raise risk of C. difficile infection:
study
Catholic Healthcare West posts stable financial performance in 2008
Study
reveals that signs of heart disease are attributed to stress more frequently
in women than men
Reminder for nominations: HPN to recognize "Supply Chain-Focused CEOs" in
January 2009 edition
FDA and PATH malaria vaccine initiative
announce research collaboration
The U.S.
Food and Drug Administration has announced a collaboration
with the PATH Malaria Vaccine Initiative (PATH-MVI) to develop
laboratory tests to better predict the level of safety and
effectiveness of experimental malaria vaccines before they are
used in human clinical trials.
PATH is an international, nonprofit organization that creates sustainable,
culturally relevant solutions to improve global health and well-being. PATH-MVI
supports the development of malaria vaccines and is expected to spearhead
the efforts to ensure their availability and accessibility in the developing
world once a safe and effective vaccine becomes available.
The PATH-MVI collaborative project is expected to span about three years and
is being conducted under the Cooperative Research and Development Agreement
(CRADA) program, which allows federal laboratories and businesses to form
partnerships that help expedite research activities. Recent scientific
advances suggest that vaccines based on live, weakened (attenuated) malaria
parasites may be possible in the future but assessing safety and
effectiveness in the early stages of product development is challenging.
Under this CRADA, PATH-MVI provides the FDA with about $1.5 million to
develop tests for evaluating malaria vaccines early in their development.
To date, there are no approved vaccines to prevent malaria but several
vaccines are in development. This CRADA will help develop laboratory tests
to assess whether a vaccine candidate is safe enough to begin Phase I
clinical trials.
The Critical Path Initiative is the FDA's effort to stimulate and facilitate
a national effort to modernize the sciences through which FDA-regulated
products are developed, evaluated and manufactured.
Family blames soldier's suicide on anti-malaria drug
Juan
Torres didn't believe that his son, Army Reservist Juan "John" M. Torres,
had killed himself in Afghanistan just weeks before he was to return home in
July 2004. He figured that John, 25, was murdered because of his opposition
to the reportedly rampant heroin trade around the base. So Torres, an
Argentine immigrant who works in the Chicago suburbs, launched his own
investigation. Now, he is convinced that his son did indeed kill himself.
But he blames Lariam, a drug taken by tourists,
Peace Corps
volunteers and troops to prevent malaria.
An Army
psychiatrist's report also suggests the medication was a factor in Torres's
suicide. Controversy swirled around Lariam in 2004 after a UPI-CNN
investigation linked it to the suicides of six Special Forces soldiers,
including three murder-suicides at North Carolina's
Fort Bragg
in the summer of 2002. Lariam is known to have serious neurological and
physical side effects, especially in users who have certain mental health
problems. The group
Lariam Action USA has catalogued numerous complaints from veterans and
others who say they suffered lasting psychological and physical side
effects, which sometimes didn't surface until years later.
The
Food and Drug Administration's
website warns of anxiety, hallucinations and other side effects, and says:
"Some patients taking Lariam think about killing themselves, and there have
been rare reports of suicides. We do not know if Lariam was responsible for
these suicides."
The Pentagon
launched an investigation into the drug in 2004, but it is still regularly
prescribed for troops in Afghanistan, Iraq and other regions. A study
published in the Feb. 11 issue of the peer-reviewed Malaria Journal
indicated that almost 10 percent of soldiers sent to Afghanistan have health
problems such as depression and bipolar disorder that put them at risk for
adverse reactions to the drug. An Army doctor who
spoke on the condition of anonymity because he doesn't have permission to
speak publicly said he was "floored" to discover while deployed in
Afghanistan this year that many troops who were on antidepressant drugs were
also prescribed Lariam.
"Not only was this unit misprescribed Lariam, this was being done with the
tacit approval of the command," the doctor said. "If a doctor is concerned
enough to prescribe an antidepressant, that would indicate they have a
problem which would indicate they should not use Lariam. Anecdotally, almost
everyone reports some side effects – strange dreams, et cetera – it’s highly
likely our folks are experiencing on a daily basis problems related to this
drug."
There are two FDA-approved alternate malaria prophylactic drugs, but Lariam
is usually preferred by the military because it is taken only once a week.
The others are taken daily. (Washington Post) Visit
here for the complete story
Hospitalized kids with painful ailments from broken bones to cancer are
often dosed with strong, painkilling drugs known as opiates. The medications
block pain, but they can have nasty side effects. Constipation, for
instance, is one side effect that can cause discomfort and even extend a
child's hospital stay.
Paul Sharek, MD, MPH, medical director for quality management and chief
clinical patient safety officer at Lucile Packard Children's Hospital at
Stanford, is the primary author of a new study, detailing the first large
multicenter trial in children to show a decrease in harm from pain
medications. It shows how simple changes to hospital procedures can sharply
reduce the harm children suffer from opiates. The study, a yearlong
collaboration between 14 U.S. children's hospitals, documented a 67 percent
drop in harmful events caused by the pain relievers when these procedures
were implemented. "Our collaborative aim was to decrease adverse drug event
rates by 50 percent," Sharek said. "We far exceeded that, which was very
exciting."
The findings are published in the October issue of Pediatrics. The
researchers focused on opiates pain-relieving drugs in the morphine family
because they're widely used and harm young patients more often than other
drugs. Forty percent of patients at children's hospitals across the U.S.
receive opiates. The vast majority of harmful incidents from the drugs, such
as constipation and skin itching, are relatively minor. But neither families
nor doctors want such problems adding to kids' days in hospital.
Hospital teams followed standard protocols for weaning patients off
long-term doses of opiates. They reduced prescription overrides in which
nurses gave pain medications to children before double-checking with a
pharmacist. And they worked hard to ensure that all caregivers had
up-to-date drug lists when patients were admitted to hospital, transferred
to new wards and sent home. The study physicians also routinely added
medications to prevent constipation.
The researchers' efforts began paying off a few months after changes were
instituted. Problems associated with opiates dropped, as the new practices
spread through each hospital. In total, the team estimated 14,594 harmful
events were averted in participating hospitals during the one-year study.
The changes also saved hospitals money, since harmful events can be costly
to resolve and often result in extended hospital stays. Visit
here for the complete story
CRC
screening before Medicare age could save millions in federal healthcare
dollars A
screening program for colon cancer in patients starting ten years prior to
Medicare eligibility, at age 55 instead of Medicare's 65, would save at
least two dollars for every dollar spent, according to a new study presented
at the American College of Gastroenterology's 73rd Annual Scientific Meeting
in Orlando.
As people get older, their risk of developing polyps and colorectal cancer
increases. Current guidelines recommend a screening colonoscopy for average
risk individuals beginning at age 50. But for many uninsured Americans, a
lack of health insurance coverage poses a barrier to screening. Medicare
coverage for most Americans begins at age 65, creating a coverage gap.
In order to determine the effect of a lack of health coverage on screening
and the cost effectiveness of screening uninsured patients, Dr. Jianjun Li
and colleagues from Maimonides Medical Center in Brooklyn offered free
colonoscopies to 248 consecutive patients (mean age 55) as part of a
colorectal cancer screening program. Nearly 45 percent of patients had
polyps. Five patients had early stage colon cancer, and 22 patients had
polyps larger than 1 cm. These large polyps are felt to have a greater risk
of harboring or developing into colorectal cancer than smaller polyps. The
screening program cost a total of $390,000.
The researchers concluded that had these patients not been screened, and the
cancers and polyps allowed to progress undetected—assuming the cost of
treatment and screening would be delayed until the Medicare eligibility age
of 65—the estimated costs would be $1,295,000. Click
here
Factors other than antibiotics may raise risk of C. difficile infection:
study
Infection with potentially deadly Clostridium difficile is often linked to
antibiotic use, but new research suggests the drugs may be getting too much
of the bad rap for the illness and that other factors may also be to blame.
In a study of C. difficile infections among people living in the community –
as opposed to those sickened by the bug while in hospital – McGill
University researchers found that a significant proportion of those who got
C. diff-related disease had not recently taken antibiotics.
Researchers analyzed health records for 836 Quebecers aged 65 or older
living in the community who contracted C. difficile-related disease that
landed them in the hospital with severe diarrhea and other symptoms.
They found that 53 percent had not taken antibiotics in the 45 days
preceding hospitalization for their infection. Expanding the analysis
further, the study showed 46 percent of subjects had not been exposed to the
drugs for 90 days prior to being admitted. C. difficile is mainly known as a
hospital-acquired infection, but the study participants had not been in
hospital for at least three months before being admitted after being
sickened by the infection, suggesting their disease was community-acquired.
"Essentially, what we were trying to address is the idea that only patients
who have taken antibiotics get C. diff," Dr. Sandra Dial, a critical-care
specialist at McGill said from Montreal. "And so what we wanted to examine
was could we confirm that people get Clostridium difficile without
antibiotic exposure." She said the main reason researchers looked at
community-acquired C. difficile is because they thought "it could make the
picture a little clearer than looking at it in a hospital where so many
things are closely tied together."
Dial said C. difficile occurs most often among patients already in hospital
because transmission is easier: patients are in close proximity, they are
already ill and are often given antibiotics. In the community, cases are
proportionately fewer and the circumstances needed for transmission are less
prevalent, she said, so other factors must come into play. Those include
people with underlying bowel disease, weakened immune systems and
disruptions to "good" intestinal flora that normally would keep C. difficile
from reproducing in large enough numbers that they produce a toxin and cause
disease. Dial also believes use of antacids known as proton pump inhibitors
may encourage serious infection because they strip away one of the body's
defenses against the bug by limiting stomach acid production.
The recognition of other risk factors should act as a red flag for
hospitals, said Dial, whose paper was published in this week's Canadian
Medical Association Journal.
"So what we're saying is if patients, particularly elderly patients, who
have any sort of bowel disorder present with severe diarrhea, still test
them for C. diff even if you don't get a history that they've been in a
hospital or that they've taken antibiotics in the recent past."
Dr. Andrew Simor, an infectious disease specialist at Sunnybrook Health
Sciences Centre in Toronto, said doctors have long known that not all cases
of C. difficile occur after taking antibiotics. The bacteria was identified
as the cause of a particular illness in the 1880s, long before antibiotics
were discovered, he said. "What's interesting in this paper, however, is the
relatively big proportion" of patients who had not taken antibiotics, he
said. "Almost half of her study population did not appear to have had prior
antibiotic exposure."
Simor agreed that hospitals should be vigilant in testing for the disease
when telltale symptoms are present, even in the absence of recent antibiotic
use and hospitalization. (Canadian Press) Visit
here for the complete story
Catholic Healthcare West posts stable financial performance in 2008
Catholic Healthcare West (CHW), the eighth largest health system in the
nation and the largest not-for-profit hospital provider in California, has
announced the results of its 2008 fiscal year, posting a net income of $170
million for the year ended June 30, compared to $891 million in the 2007
fiscal year, which included the effect of a change in accounting for
unrealized gains and losses. This change in reporting rules for unrealized
gains and losses on investments resulted in additional investment income of
$194 million in FY07 that related to prior years.
Operating income for the not-for-profit hospital system in FY08 was $160
million compared to an operating income of $300 million in FY07. Revenues
for FY08 increased 12 percent to $8.4 billion, compared to $7.8 billion in
FY07. Across the 41-hospital system, adjusted admissions increased by 5.4
percent during the fiscal year, bringing its three-year increase to 12
percent. Results were released following a standard audit of financial
statements.
CHW's income statement was impacted during the year by a non-recurring item
– a mold remediation project at St. John's Regional Medical Center in
Oxnard, CA – and several non-cash accounting entries, including the cost of
restructuring debt and the aforementioned change in reporting rules for
unrealized gains and losses on investments. Without these events, net income
for the 2008 fiscal year would have been $485 million.
During FY08, CHW provided $508 million in community benefits and free care
for the poor, including charity care, community grants, and free primary
care, up from $501 million in FY07. Based on guidance from the Catholic
Health Association, CHW does not count its Medicare shortfall as part of
community benefits. The Medicare shortfall to CHW in FY08 was $459 million,
bringing the total FY08 unreimbursed expense to $967 million for both
patient care and proactive health improvement efforts.
CHW also reinvested nearly $800 million in capital improvements and
technology, including the continued roll-out if its clinical information
system to a number of facilities; construction of a new hospital in Merced,
CA; new patient towers at Mercy San Juan Medical Center in Carmichael, CA,
and St. Joseph's Medical Center in Stockton, CA; and expansions at Mercy
Gilbert Medical Center in Gilbert, AZ, and Bakersfield Memorial Hospital in
Bakersfield, CA. For more information, please visit
www.chwHEALTH.org.
Study reveals that signs of heart disease are attributed to stress more
frequently in women than men
Research presented at the 20th annual Transcatheter Cardiovascular
Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular
Research Foundation (CRF), found that coronary heart disease (CHD) symptoms
presented in the context of a stressful life event were identified as
psychogenic in origin when presented by women and organic in origin when
presented by men. The study could help explain why there is often a delay in
the assessment of women with heart disease.
"We know that there is a delay in diagnosing CHD in women and this is an
important step forward in understanding why," said Alexandra J. Lansky,
M.D., director of the Women's Health Initiative at CRF, director of Clinical
Services at the Center for Interventional Vascular Therapy, a cardiologist
at NewYork-Presbyterian Hospital/Columbia University Medical Center, and an
associate professor of clinical medicine at Columbia University College of
Physicians and Surgeons.
The investigation – "Gender Bias in the Diagnosis, Treatment, and
Interpretation of CHD Symptoms: Two Experimental Studies with Internists and
Family Physicians," was led by Gabrielle R. Chiaramonte, Ph.D., postdoctoral
associate at the Weill Medical College of Cornell University and Clinical
Fellow at NewYork-Presbyterian Hospital. The study examined the effects of
patients' gender and the context of how CHD symptoms are presented
(with/without mention of life stressors and anxiety) on primary care
physicians' patient evaluations.
The researchers hypothesized that the presence of life stressors/anxiety
would shift the interpretation of women's, but not men's, CHD symptoms, so
that these would be perceived to have a psychogenic etiology. "The greater
prevalence of anxiety disorders in women, along with the greater likelihood
that women will discuss stressors with their physicians, and the overlap of
CHD and anxiety symptoms, contribute to this shift in interpretation," Dr.
Chiaramonte said.
As the investigators predicted, results showed a gender bias when CHD
symptoms were presented in the context of stress, with fewer women receiving
CHD diagnoses (15% versus 56%), cardiologist referrals (30% versus 62%), and
prescriptions of cardiac medication (13% versus 47%) than men. No evidence
of a bias was observed when CHD symptoms were presented without the stress.
Results also showed that the presence of stress shifted the interpretation
of women's chest pain, shortness of breath and irregular heart rate so that
these were thought to have a psychogenic origin. By contrast, men's symptoms
were perceived as organic whether or not stressors were present.
For more information, visit
www.crf.org. For the complete story visit
here
Reminder for nominations: HPN to recognize "Supply Chain-Focused CEOs" in
January 2009 edition
Many industries outside of healthcare recognize and respect the value that
effective and efficient supply chain management contributes to the top and
bottom lines. Among healthcare providers, such recognition and support is
growing, slowly but surely, from the top post in the executive suite.
That’s why
Healthcare Purchasing News
launched its yearly search for "supply chain focused CEOs four years ago. We
wanted to locate forward-thinking men and women to share their insights with
you, and you’ve helped us do that. In fact, we’ve profiled of 13 of them
already since January 2005.
Well, it’s that time of the year again – time to nominate noteworthy
hospital presidents/CEOs for HPN’s 5th Annual "S.U.R.E. Award for Supply
Chain Focused CEOs" award. We’re looking to recognize chief executives who
support, understand, recognize and empower the materials management
department to do what needs to be done to achieve bottom-line savings and
top-line revenue.
We ask you, our dedicated and loyal readers, to recommend worthy candidates
for recognition in our January 2009 edition by e-mailing us reasons how and
why your CEO deserves the spotlight – no more than a couple of paragraphs
are needed for each of the four S.U.R.E. categories listed above that
comprise the "SURE" acronym. Please describe how and why he or she supports,
how and why he or she understands, how and why he or she recognizes and how
and why he or she empowers the materials management department and its top
executive.
For your nomination to qualify, please be sure to comply with our submission
rules. Click here
for details.
Nominations are due by Friday, November 7.
Thanks in advance. |